A detailed history of Centaurus Financial, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Centaurus Financial, Inc. holds 282 shares of MCK stock, worth $146,592. This represents 0.01% of its overall portfolio holdings.

Number of Shares
282
Previous 282 -0.0%
Holding current value
$146,592
Previous $130,000 16.15%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$402.4 - $446.42 $11,267 - $12,499
28 Added 11.02%
282 $123,000
Q2 2023

Aug 15, 2023

SELL
$354.01 - $427.31 $307,280 - $370,905
-868 Reduced 77.36%
254 $108,000
Q1 2023

May 17, 2023

BUY
$335.35 - $386.06 $194,838 - $224,300
581 Added 107.39%
1,122 $399,000
Q4 2022

Feb 10, 2023

SELL
$346.68 - $397.58 $134,858 - $154,658
-389 Reduced 41.83%
541 $202,000
Q3 2022

Dec 05, 2022

BUY
$321.25 - $373.84 $123,038 - $143,180
383 Added 70.02%
930 $316,000
Q2 2022

Aug 02, 2022

BUY
$300.57 - $336.42 $9,017 - $10,092
30 Added 5.8%
547 $178,000
Q1 2022

May 13, 2022

BUY
$244.61 - $310.48 $26,662 - $33,842
109 Added 26.72%
517 $158,000
Q4 2021

Feb 01, 2022

BUY
$198.21 - $248.9 $80,869 - $101,551
408 New
408 $101,000
Q2 2019

Aug 15, 2019

SELL
$112.47 - $134.93 $24,293 - $29,144
-216 Closed
0 $0
Q1 2019

Jul 01, 2019

SELL
$111.86 - $136.3 $182,331 - $222,169
-1,630 Reduced 88.3%
216 $1.85 Million
Q1 2019

May 13, 2019

BUY
$111.86 - $136.3 $184,792 - $225,167
1,652 Added 851.55%
1,846 $216,000
Q4 2018

Feb 12, 2019

BUY
$108.23 - $136.84 $20,780 - $26,273
192 Added 9600.0%
194 $2,000
Q3 2018

Nov 05, 2018

SELL
$123.14 - $138.52 $84,350 - $94,886
-685 Reduced 99.71%
2 $233,000
Q2 2018

Aug 15, 2018

BUY
$133.4 - $158.13 $91,645 - $108,635
687 New
687 $92,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $74.7B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.